The effect and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancer.
Sign Up to like & getrecommendations! Published in 2019 at "Japanese journal of clinical oncology"
DOI: 10.1093/jjco/hyz066
Abstract: INTRODUCTION Immune checkpoint inhibitors (ICIs) have demonstrated long survival for the treatment of advanced non-small cell lung cancer (NSCLC). However, the effect and safety of ICI rechallenge have not been fully evaluated. The aim of… read more here.
Keywords: immune checkpoint; safety; effect; ici rechallenge ... See more keywords